Equities

Tatva Chintan Pharma Chem Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Tatva Chintan Pharma Chem Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)1,129.10
  • Today's Change20.10 / 1.81%
  • Shares traded40.24k
  • 1 Year change+57.72%
  • Beta0.8921
Data delayed at least 15 minutes, as of Mar 05 2026 07:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is engaged in the manufacturing of a variety of chemicals, including structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts and solutions (ESS) for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are used for forming channels in zeolites. Its PTCs are used in heterogeneous multiphase systems, facilitating reactant migration. It operates through the Specialty chemical segment. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. It caters to various customers across various industries, including the automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances industries. The Company’s subsidiaries are Tatva Chintan Europe B.V. and Tatva Chintan USA Inc.

  • Revenue in INR (TTM)4.80bn
  • Net income in INR327.63m
  • Incorporated1996
  • Employees679.00
  • Location
    Tatva Chintan Pharma Chem LtdPlot No. 353 G.I.D.C, MakarpuraVADODARA 390010IndiaIND
  • Phone+91 7 574848533
  • Websitehttps://www.tatvachintan.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nocil Ltd13.12bn594.20m22.52bn737.0037.88--19.741.723.563.5678.57--------17,806,110.00--7.16--8.0141.7731.454.539.35--41.73--33.36-3.6010.48-22.66-4.67-7.36--
Bharat Rasayan Ltd12.40bn1.33bn23.53bn651.0017.73--14.761.9079.8479.84746.29--------19,053,040.00--13.11--16.3234.1127.0910.7011.99--36.61--0.446612.29-0.701947.54-2.22-9.390.00
Sirca Paints India Ltd4.59bn614.45m24.86bn659.0039.48--35.015.4111.0911.0982.95--------6,969,625.00--12.64--14.7946.4640.7413.3814.72--21.27----19.9822.59-4.6214.2936.45--
Polyplex Corp Ltd69.55bn302.58m25.39bn935.0083.91--7.480.36529.649.642,215.30--------74,381,870.00--8.22--14.9431.1231.61-0.0778.91--0.6342--42.249.178.94453.00-5.801.26-4.51
Kiri Industries Ltd7.94bn49.67bn25.58bn811.000.543--0.52813.22784.73784.73142.08--------9,792,472.00--7.41--8.6025.1218.93603.9324.32--------4.43-10.7359.26-6.7529.18--
Fineotex Chemical Ltd5.78bn971.13m25.79bn210.0025.15--22.954.460.88070.88075.22--------27,536,990.00--20.17--24.2935.8036.5617.5319.09--89.09--6.19-6.2622.12-9.6852.6061.0074.11
Tatva Chintan Pharma Chem Ltd4.80bn327.63m25.98bn679.0079.26--38.715.4214.0114.01205.18--------7,063,005.00--7.43--9.6052.8742.226.8311.88--21.79--6.91-2.747.77-81.18-31.479.63--
Bhagiradha Chemicals and Industries Ltd5.00bn132.15m26.08bn546.00199.11--88.385.211.011.0140.19--------9,166,097.00--6.15--8.3935.6026.132.646.48--2.30--7.258.0512.39-23.9516.3245.39--
Rossari Biotech Ltd22.91bn1.38bn26.32bn535.0019.13--12.441.1524.8424.84413.31--------42,823,640.00--9.29--12.6031.2729.566.017.12--8.71--2.4613.6428.234.3515.8915.85--
Camlin Fine Sciences Ltd17.55bn1.71bn26.73bn661.0013.52--11.601.5210.29-3.2595.63--------26,547,460.00--3.00--4.8547.1538.429.663.62--1.33--0.0014.629.705.2217.70-20.56--
Jubilant Agri and Consumer Products Ltd18.04bn1.24bn27.08bn1.40k22.27--19.181.5080.2480.241,161.64--------12,850,290.00--------41.73--6.87----24.29----24.56--187.85------
Premier Explosives Ltd3.73bn429.74m27.09bn838.0063.01--49.457.268.008.0069.45--------4,453,657.00--3.19--5.1844.9647.7811.524.69--9.72--15.1153.6420.471.19---14.55--
Ddev Plastiks Industries Ltd29.19bn1.99bn27.43bn400.0013.79--12.670.939819.2319.23281.97--------72,975,060.00--------17.21--6.82----10.28----7.08--2.11------
NACL Industries Ltd14.25bn-445.70m28.46bn1.35k------2.00-2.06-2.0665.81--------10,578,620.00--0.9308--2.1730.1020.61-3.130.8582---0.2909--44.83-30.604.00-56.44---13.76--
Krishana Phoschem Ltd21.35bn1.30bn28.75bn267.0022.13--17.621.3521.0221.02345.46--------79,977,190.00--7.95--11.8230.1630.156.086.51--6.99--5.1947.0152.82113.9844.4298.7814.87
Data as of Mar 05 2026. Currency figures normalised to Tatva Chintan Pharma Chem Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

6.69%Per cent of shares held by top holders
HolderShares% Held
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 04 Jul 2025740.25k3.17%
Goldman Sachs Asset Management LPas of 06 Feb 2026626.96k2.68%
ICICI Prudential Asset Management Co. Ltd. (Invt Mgmt)as of 31 Jan 2026123.84k0.53%
Mediolanum International Funds Ltd.as of 30 Sep 202539.95k0.17%
SSgA Funds Management, Inc.as of 05 Feb 202615.73k0.07%
Dimensional Fund Advisors LPas of 05 Feb 202614.11k0.06%
American Century Investment Management, Inc.as of 05 Feb 20263.25k0.01%
DFA Australia Ltd.as of 30 Nov 202541.000.00%
Motilal Oswal Asset Management Co. Ltd.as of 31 Jan 202618.000.00%
More ▼
Data from 31 Dec 2025 - 26 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.